标题/作者	年份
Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis Y Feng, M Spezia, S Huang, C Yuan, Z Zeng, L Zhang, X Ji, W Liu, ... Genes & diseases 5 (2), 77-106	2018
Cancer health disparities in racial/ethnic minorities in the United States VA Zavala, PM Bracci, JM Carethers, L Carvajal-Carmona, NB Coggins, ... British journal of cancer 124 (2), 315-332	2021
Early detection of pancreatic cancer SP Pereira, L Oldfield, A Ney, PA Hart, MG Keane, SJ Pandol, D Li, ... The lancet Gastroenterology & hepatology 5 (7), 698-710	2020
BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2 MS Cline, RG Liao, MT Parsons, B Paten, F Alquaddoomi, A Antoniou, ... PLoS genetics 14 (12), e1007752	2018
Insights into breast cancer in the east vs the west: a review YS Yap, YS Lu, K Tamura, JE Lee, EY Ko, YH Park, AY Cao, CH Lin, ... JAMA oncology 5 (10), 1489-1496	2019
Direct-to-consumer genetic testing R Horton, G Crawford, L Freeman, A Fenwick, CF Wright, A Lucassen Bmj 367	2019
Exome sequencing reveals a high prevalence of BRCA1 and BRCA2 founder variants in a diverse population-based biobank NS Abul-Husn, ER Soper, JA Odgis, S Cullina, D Bobo, A Moscati, ... Genome Medicine 12 (1), 1-12	2020
Resolving gastric cancer aetiology: an update in genetic predisposition PC Lott, LG Carvajal-Carmona The lancet Gastroenterology & hepatology 3 (12), 874-883	2018
Unique roles of rare variants in the genetics of complex diseases in humans Y Momozawa, K Mizukami Journal of human genetics 66 (1), 11-23	2021
African genetic diversity and adaptation inform a precision medicine agenda L Pereira, L Mutesa, P Tindana, M Ramsay Nature Reviews Genetics 22 (5), 284-306	2021
Germline variation in BRCA1/2 is highly ethnic‐specific: Evidence from over 30,000 Chinese hereditary breast and ovarian cancer patients SP Bhaskaran, K Chandratre, H Gupta, L Zhang, X Wang, J Cui, YC Kim, ... International journal of cancer 145 (4), 962-973	2019
Contribution of germline predisposition gene mutations to breast cancer risk in African American women JR Palmer, EC Polley, C Hu, EM John, C Haiman, SN Hart, M Gaudet, ... JNCI: Journal of the National Cancer Institute 112 (12), 1213-1221	2020
1 in 38 individuals at risk of a dominant medically actionable disease L Haer-Wigman, V van der Schoot, I Feenstra, AT Vulto-van Silfhout, ... European Journal of Human Genetics 27 (2), 325-330	2019
Prevalence of inherited mutations in breast cancer predisposition genes among women in Uganda and Cameroon B Adedokun, Y Zheng, P Ndom, A Gakwaya, T Makumbi, AY Zhou, ... Cancer Epidemiology, Biomarkers & Prevention 29 (2), 359-367	2020
Spectrum and prevalence of pathogenic variants in ovarian cancer susceptibility genes in a group of 333 patients M Koczkowska, N Krawczynska, M Stukan, A Kuzniacka, I Brozek, ... Cancers 10 (11), 442	2018
Germline BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance associated with breast/ovarian cancer: a report from North India A Mehta, S Vasudevan, SK Sharma, D Kumar, M Panigrahi, ... Cancer management and research, 6505-6516	2018
Targeted deep sequencing revealed variants in cell-free DNA of hormone receptor-positive metastatic breast cancer patients C Keup, K Benyaa, S Hauch, M Sprenger-Haussels, M Tewes, P Mach, ... Cellular and Molecular Life Sciences 77 (3), 497-509	2020
BRCA1 and BRCA2 pathogenic sequence variants in women of African origin or ancestry TM Friebel, IL Andrulis, J Balmaña, AM Blanco, FJ Couch, MB Daly, ... Human mutation 40 (10), 1781-1796	2019
One in three highly selected Greek patients with breast cancer carries a loss-of-function variant in a cancer susceptibility gene F Fostira, I Kostantopoulou, P Apostolou, MS Papamentzelopoulou, ... Journal of Medical Genetics 57 (1), 53-61	2020
Cancer in sub-saharan africa TR Rebbeck Science 367 (6473), 27-28	2020

1 - 20

计算机程序会自动估算并确定日期和引用次数。